Search

Issue
Title
Authors
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O.A., Torshin I.Y., Limanova O.A., Grishina T.R., Gromov A.N.
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S.V., Biryukova E.V., Solovievа I.V.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A.E., Shchukina E.V., Efremenko V.A., Mikhailichenko E.S., Suprun E.V.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M.B., Zilov A.V., Koteshkova O.M., Demidov N.A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.Y.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.S.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.A.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.A.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A.F., Sharonova L.A., Verbovaya N.I., Demidova D.V., Kapishnikov A.V.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.A.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N.A., Knyshenko O.A., Ivanova L.P.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.Y.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V.A., Peterkova V.A.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I.V., Nechaeva G.I., Korennova O.Y., Druk I.V., Nechayeva G.I., Korennova O.Y.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I.Y., Bagriy A.E., Mikhailichenko E.S., Kutya A.E., Sovpel Y.A.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A.I., Pereverzev A.P., Ostroumova O.D., Gusenbekova D.G., Romanovsky R.R., Shatalova N.A.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A.P., Ostroumova O.D., Tkacheva O.N.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Fabritskaya S.V., Poletaeva L.V.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T.I., Popkova E.N., Trel'skaya N.Y., Emel'yanov V.V., Severina T.I., Popkova Y.N., Trelskaya N.Y., Yemelyanov V.V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Trukhina L.V., Petunina N.A., Truhina L.V.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M.B., Morgunov L.Y., Antsiferov M.B., Morgunov L.Y.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.V.
Advance - movement forward
Petunina N.A., Petunina N.
Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone
Elsukova O.S., Nikitina E.A.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.Y.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E.V., Shinkin M.V., Morozova I.A.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O.D., Goloborodova I.V.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I.G., Petryaykina E.E., Koltunov I.E.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.A.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N.A., Antsiferov M.B.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M.B., Petunina N.A., Antsiferov M.B., Petunina N.A.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M.B., Koteshkova O.M., Kleymenova S.A., Antsiferov M.B., Koteshkova O.M., Kleimenko S.A.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L.V., Nedosugova L.
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Y.V.
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T.V., Vezikova N.N.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N.A., Degtyareva E.I.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A.D., Zhulina Y.S., Rozhkova V.V., Martynova E.Y., Poteshkin Y.E.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A.F., Pashentseva A.V., Verbovaya N.I., Kosareva O.V.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.B.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N.A., Ivanova L.P., Abaeva F.T.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A.S., Tertychnaya E.A.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antciferov M.B.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y.V., Biryukova E.V.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V.V., Chazova I., Fomin V.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M.B., Antsiferov M.
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children
Sadykova D.I., Shaydullina M.R., Aksenova A.A., Galimova L.F.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I.Y., Boeva V.V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I.B., Gubachikova A.M., Aramisova L.S., Anaeva L.A., Abdul Moati H.A.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K.S., Gatina A.I., Gorbunova Y.S., Demidov N.A., Ivanenko T.S., Kolesnikova M.I., Lapteva O.A., Morozova I.V., Parshina V.A., Presnyakova O.Y., Smirnova E.Y., Smirnova N.P., Startseva M.A., Khamrazhanov Z.A., Kholmskaya N.I.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.Y.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»
Antsiferov M.B., Galstyan G.R.
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G.I., Novikova L.B.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.Y.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E.Y., Antsiferov M.B.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E.V., Tyulganova V.L.
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M.F., Zilov A.V., Yazykova D.R., Likhodey N.V., Fadeev V.V.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I.G., Vinnytskaya E.V., Sandler Y.G., Keiyan V.A., Rodionova S.V.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.M.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.V.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.S.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E.V., Danilova T.B.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I.V., Romantsova T.I., Glinkina I.V., Romantsova T.I.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E.V., pl?midmagidsid Y.h.
1 - 100 of 185 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"